Vimarsana
Biggest News Aggregation in the World

Basser Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Basser Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Basser Center Today - Breaking & Trending Today

Dr Maxwell on Real-World Germline Variant Rates in Prostate Cancer - Vimarsana News

Dr Maxwell on Real-World Germline Variant Rates in Prostate Cancer

Kara N. Maxwell, MD, PhD, discusses key takeaways from a real-world investigation of germline mutation rates in patients with metastatic prostate cancer.

Dr Maxwell on the Accessibility of Genetic Testing in Metastatic Prostate Cancer - Vimarsana News

Dr Maxwell on the Accessibility of Genetic Testing in Metastatic Prostate Cancer

Kara N. Maxwell, MD, PhD, discusses the accessibility of genetic testing in the community setting for patients with metastatic prostate cancer.

Best-selling author and former White House Official Alejandra Campoverdi to deliver Northeastern Illinois University Commencement Address - Vimarsana News

Best-selling author and former White House Official Alejandra Campoverdi to deliver Northeastern Illinois University Commencement Address

/PRNewswire/ -- Nationally recognized women's health advocate and former White House aide Alejandra Campoverdi will be Northeastern Illinois University's May...

Dr Maxwell on Strategies to Optimize Genetic Testing in Metastatic Prostate Cancer - Vimarsana News

Dr Maxwell on Strategies to Optimize Genetic Testing in Metastatic Prostate Cancer

Kara N. Maxwell, MD, PhD, discusses strategies to optimize the utility of genetic testing to better inform decision-making in prostate cancer treatment.

Comparable Germline Variant Rates Seen Across Racial Groups in Metastatic Prostate Cancer - Vimarsana News

Comparable Germline Variant Rates Seen Across Racial Groups in Metastatic Prostate Cancer

Kara N. Maxwell, MD, PhD, discusses the prevalence of germline mutations in racially diverse cohorts of patients with metastatic prostate cancer.